Radient Technologies (Radient Technologies) Cash And Cash Equivalents : $0.08 Mil (As of Dec. 2022)

View and export this data going back to 2016. Start your Free Trial

What is Radient Technologies Cash And Cash Equivalents?

Radient Technologies's quarterly cash and cash equivalents increased from Jun. 2022 ($0.03 Mil) to Sep. 2022 ($0.16 Mil) but then stayed the same from Sep. 2022 ($0.16 Mil) to Dec. 2022 ($0.08 Mil).

Radient Technologies's annual cash and cash equivalents increased from Mar. 2020 ($0.10 Mil) to Mar. 2021 ($0.39 Mil) but then declined from Mar. 2021 ($0.39 Mil) to Mar. 2022 ($0.03 Mil).

Radient Technologies Cash And Cash Equivalents Historical Data

The historical data trend for Radient Technologies's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Radient Technologies Cash And Cash Equivalents Chart

Radient Technologies Annual Data

Trend

Dec13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Cash And Cash Equivalents

Get a 7-Day Free Trial

16.90

23.75

0.10

0.39

0.03

Radient Technologies Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Cash And Cash Equivalents	Get a 7-Day Free Trial															1.03	0.03	0.03	0.16	0.08

Radient Technologies Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Radient Technologies (OTCPK:RDDTF) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Radient Technologies Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Radient Technologies's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Radient Technologies (Radient Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Radient Technologies Inc (OTCPK:RDDTF) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

4035 101 St. NW, Edmonton, AB, CAN, T6E 0A4

Website

https://www.radientinc.com

Radient Technologies Inc is a Canadian company engaged in manufacturing cannabis derivatives, formulations, and products. It has developed its extraction process, Microwave Assisted Processing (MAP), which is used for producing a consistent product at industrial-scale quantities. It provides its customers and partners with white-label extracts, formulations, and finished products that contain a broad spectrum of cannabinoid and terpene profiles. While it operates in Canada and is building an additional facility in Germany. It operates in a single segment namely the production and sale of cannabis-related retail products.